Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation!

Episode contents:

- A review of what to look at on the bone marrow biopsy report

- WHO and ICC classification for AML and MDS

- Disease-defining cytogenetic markers to be aware of and their prognostic implications